Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
13.14
-0.23 (-1.72%)
At close: Sep 4, 2026, 4:00 PM EDT
13.24
+0.10 (0.76%)
After-hours: Sep 4, 2026, 7:30 PM EDT
TNXP Market Cap
TNXP has a market cap or net worth of $225.36 million as of September 4, 2026. Its market cap has decreased by -7.19% in one year.
Market Cap
225.36M
Enterprise Value
50.40M
1-Year Change
-7.19%
Ranking
Category
Stock Price
$13.14
ChartMarket Cap Chart
Since July 16, 2019, TNXP's market cap has increased from $7.29M to $225.36M, an increase of 2,989.87%. That is a compound annual growth rate of 61.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 225.36M | 16.43% |
| Dec 31, 2025 | 193.56M | 214.02% |
| Dec 31, 2024 | 61.64M | 160.94% |
| Dec 29, 2023 | 23.62M | 5.35% |
| Dec 30, 2022 | 22.42M | -87.36% |
| Dec 31, 2021 | 177.42M | 37.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Compugen | 242.02M |
| Eledon Pharmaceuticals | 238.33M |
| Protara Therapeutics | 234.61M |
| Sol-Gel Technologies | 229.51M |
| Greenwich LifeSciences | 229.42M |
| AN2 Therapeutics | 224.53M |
| Minerva Neurosciences | 223.94M |
| Acumen Pharmaceuticals | 223.46M |